A Rare but Increasing Threat: An Evaluation of Regional and Single-Institution Trends in Merkel Cell Carcinoma
Journal of Surgical Research · 2026
DOI: 10.1016/j.jss.2025.10.032 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Research, 2026. Verfasst von Megan Kolbe und 4 weiteren Autor:innen. Beteiligte Einrichtung: Virginia Commonwealth University, School of Medicine, Richmond, Virginia. Hauptthemen laut MEDLINE: Carcinoma, Merkel Cell, Skin Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
INTRODUCTION: Merkel cell carcinoma (MCC) is a rare but aggressive cutaneous neuroendocrine tumor with high mortality rates. Recent US population studies have shown that the incidence of MCC is increasing. We aim to describe our institution's epidemiological trends and compare them with the National Cancer Institute's Surveillance, Epidemiology, and End Results database to determine if there is a region-specific increase in disease incidence. METHODS: We conducted a retrospective, single-institution review of patients diagnosed with MCC between 2010 and 2023. We evaluated the 5-y overall survival (OS) and recurrence-free survival. Kaplan-Meier estimates were used to assess the primary outcomes. The log-tank test and Cox regression modeling was performed to evaluate which factors influenced OS. We compared National Cancer Institute's Surveillance, Epidemiology, and End Results regional (Northeast, Midwest, South, and West) incidences between 2010 and 2021 to those of our cohort. RESULTS: Between 2010 and 2021, the incidence of MCC has increased within the United States from 7.0 to 8.2 per million. These increases were most pronounced in the South region between 2018 and 2021. We identified 82 patients diagnosed with MCC at our institution, with increasing cases starting in 2017. The 5-y OS was 52.9%, and recurrence-free survival stabilized at 68.8% after 2 y. The results of the OS subgroup comparisons indicated that age at diagnosis, Charlson Comorbidity Index, Eastern Cooperative Oncology Group, and treatment with chemotherapy were significantly associated with OS. CONCLUSIONS: Akin to our experience in Virginia, the increase in MCC incidence is most pronounced in the southern states. As anticipated, our outcomes were influenced by patient comorbidities, advanced age, and need for systemic therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Virginia Commonwealth University, School of Medicine, Richmond, Virginia.
- Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia.
- Virginia Commonwealth University, Massey Comprehensive Cancer Center, Biostatistics Shared Resource, Richmond, Virginia.
- Division of Surgical Oncology, Department of Surgery, Virginia Commonwealth University, Richmond, Virginia. Electronic address: Raphael.Louie@vcuhealth.org.
Zitieren
APA
Kolbe, M., Francis, A., He, J., Schmidt, B., & Louie, R. (2026). A Rare but Increasing Threat: An Evaluation of Regional and Single-Institution Trends in Merkel Cell Carcinoma. Journal of Surgical Research. https://doi.org/10.1016/j.jss.2025.10.032
Vancouver
Kolbe M, Francis A, He J, Schmidt B, Louie R. A Rare but Increasing Threat: An Evaluation of Regional and Single-Institution Trends in Merkel Cell Carcinoma. Journal of Surgical Research. 2026. doi:10.1016/j.jss.2025.10.032
BibTeX
@article{Kolbe2026,
author = {Kolbe, Megan and Francis, Andrew and He, Jian and Schmidt, Benjamin and Louie, Raphael},
title = {A Rare but Increasing Threat: An Evaluation of Regional and Single-Institution Trends in Merkel Cell Carcinoma},
journal = {Journal of Surgical Research},
year = {2026},
doi = {10.1016/j.jss.2025.10.032}
}
EUVIMED